Snowball logo
logo
BDTX_logo

Black Diamond Therapeutics, Inc

BDTX NASDAQ
$2.255+$0.095  (4.4%)

Frequently asked questions

What sector does Black Diamond Therapeutics, Inc (BDTX) operate in?

Black Diamond Therapeutics, Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Black Diamond Therapeutics, Inc (BDTX) current stock price?

As of the latest data, Black Diamond Therapeutics, Inc stock price is $2.26, with a previous close of $2.16. Black Diamond Therapeutics, Inc gained $0.10 in the last trading session, representing a 4.4% increase.

What is Black Diamond Therapeutics, Inc (BDTX) current market capitalization?

Black Diamond Therapeutics, Inc market cap is approximately 128.48 million.

What is Black Diamond Therapeutics, Inc (BDTX) Earnings Per Share (EPS)?

The trailing EPS is $0.37, and the forward EPS is -$0.60.

What is Black Diamond Therapeutics, Inc (BDTX) Price-to-Earnings (P/E) ratio?

Black Diamond Therapeutics, Inc current P/E ratio is 6.09.

What is Black Diamond Therapeutics, Inc (BDTX) EBITDA?

Black Diamond Therapeutics, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -8.41 million.

Does Black Diamond Therapeutics, Inc (BDTX) pay dividends?

No. Black Diamond Therapeutics, Inc does not pay a dividend.

When is Black Diamond Therapeutics, Inc (BDTX) next earnings report?

Black Diamond Therapeutics, Inc is expected to release its next earnings report on December 31, 2025.

What is Black Diamond Therapeutics, Inc (BDTX) beta (volatility) score?

Black Diamond Therapeutics, Inc has a beta of 3.405, indicating very high volatility compared to the market.